Aap Implantate AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
aap Implantate AG issues Sales and EBITDA guidance for Q1 2014 and fiscal 2014 in line with analysts estimates
aap Implantate AG:Announces that for 2014 the Management Board anticipates sales growth of approximately 10 percent to 44 million euros and an EBITDA between 6 million euros and 8 million euros, fiscal 2014 sales 44.52 million euros and EBITDA 8.11 million euros - Thomson Reuters I/B/E/S.Sees in the first quarter of 2014 it sales of between 8 million euros and 9 million euros and an EBITDA between 0.5 million euros and 1.5 million euros.
Latest Developments for Aap Implantate AG
- aap Implantate AG issues FY 2014 Q3 outlook and reaffirms FY 2014 outlook
- aap Implantate AG completes spin off of its non-core business dental
- aap Implantate AG issues FY 2014 Q2 outlook; reaffirms FY 2014 outlook
- aap Implantate AG announces Bruke Seyoum Alemu as company's new Chairman of Management Board and Chief Executive Officer
Latest Key Developments in Medical
- Share this
- Digg this